354 related articles for article (PubMed ID: 10897007)
21. Detection of ductal carcinoma in situ with mammography, breast specific gamma imaging, and magnetic resonance imaging: a comparative study.
Brem RF; Fishman M; Rapelyea JA
Acad Radiol; 2007 Aug; 14(8):945-50. PubMed ID: 17659240
[TBL] [Abstract][Full Text] [Related]
22. Comparison between breast MRI and contrast-enhanced spectral mammography.
Łuczyńska E; Heinze-Paluchowska S; Hendrick E; Dyczek S; Ryś J; Herman K; Blecharz P; Jakubowicz J
Med Sci Monit; 2015 May; 21():1358-67. PubMed ID: 25963880
[TBL] [Abstract][Full Text] [Related]
23. Scintimammography with technetium-99m tetrofosmin in suspected breast cancer.
Schillaci O; Scopinaro F; Danieli R; Picardi V; Tavolaro R; Cannas P; Colella AC
Anticancer Res; 1997; 17(3B):1623-6. PubMed ID: 9179206
[TBL] [Abstract][Full Text] [Related]
24. Colorectal cancer imaging with iodine-123-labeled CEA monoclonal antibody fragments.
Goldenberg DM; Wlodkowski TJ; Sharkey RM; Silberstein EB; Serafini AN; Garty II; Van Heertum RL; Higginbotham-Ford EA; Kotler JA; Balasubramanian N
J Nucl Med; 1993 Jan; 34(1):61-70. PubMed ID: 8418273
[TBL] [Abstract][Full Text] [Related]
25. Mammographic features of invasive lobular and invasive ductal carcinoma of the breast: a comparative analysis.
Cornford EJ; Wilson AR; Athanassiou E; Galea M; Ellis IO; Elston CW; Blamey RW
Br J Radiol; 1995 May; 68(809):450-3. PubMed ID: 7788227
[TBL] [Abstract][Full Text] [Related]
26. Mammographic screening for breast cancer in a resource-restricted environment.
Apffelstaedt SP; Dalmayer L; Baatjes K
S Afr Med J; 2014 Apr; 104(4):294-6. PubMed ID: 25118556
[TBL] [Abstract][Full Text] [Related]
27. [A Spanish multicenter scintigraphic study of the breast using Tc 99m MIBI. Report of results].
Prats E; Carril J; Herranz R; Meroño E; Banzo J; Gtemegmmt YE
Rev Esp Med Nucl; 1998; 17(5):338-50. PubMed ID: 9812008
[TBL] [Abstract][Full Text] [Related]
28. Detection of colorectal carcinoma by anti-CEA monoclonal antibody (IOR-CEA1) labeled with 99mTc scintigraphy.
Sirisriro R; Boonkitticharoen V; Kraiphibul P; Ratanatharathorn V; Sumboonnanon K; Kanjanapitak A; Kuhapremma T; Sritara C; Puchinda D; Chouplywech P; Jalayondeja V; Pekanan P; Rochanawutanon M; Intaramarn C; Ayudhya AN; Chokesuwathana P
Hepatogastroenterology; 2000; 47(32):405-13. PubMed ID: 10791201
[TBL] [Abstract][Full Text] [Related]
29. Tc-99m-tetrofosmin scintimammography: a prospective study in primary breast lesions.
Lind P; Gallowitsch HJ; Kogler D; Kresnik E; Mikosch P; Gomez I
Nuklearmedizin; 1996 Dec; 35(6):225-9. PubMed ID: 8976502
[TBL] [Abstract][Full Text] [Related]
30. Scintimammographic analysis of nonpalpable breast lesions previously identified by conventional mammography.
Tolmos J; Cutrone JA; Wang B; Vargas HI; Stuntz M; Mishkin FS; Diggles LE; Venegas RJ; Klein SR; Khalkhali I
J Natl Cancer Inst; 1998 Jun; 90(11):846-9. PubMed ID: 9625173
[TBL] [Abstract][Full Text] [Related]
31. Breast-specific gamma imaging as an adjunct imaging modality for the diagnosis of breast cancer.
Brem RF; Floerke AC; Rapelyea JA; Teal C; Kelly T; Mathur V
Radiology; 2008 Jun; 247(3):651-7. PubMed ID: 18487533
[TBL] [Abstract][Full Text] [Related]
32. Initial experience of automated breast volume scanning (ABVS) and ultrasound elastography in predicting breast cancer subtypes and staging.
Wang XL; Tao L; Zhou XL; Wei H; Sun JW
Breast; 2016 Dec; 30():130-135. PubMed ID: 27718417
[TBL] [Abstract][Full Text] [Related]
33. Scintimammography using Tc-99m tetrofosmin.
Lind P; Umschaden HW; Forsthuber E; Oman J; Kerschbaumer K; Gallowitsch HJ; Mikosch P; Kresnik E; Molnar M; Gomez I
Acta Med Austriaca; 1997; 24(2):50-4. PubMed ID: 9227787
[TBL] [Abstract][Full Text] [Related]
34. Comparison of complete versus fragmented technetium-99m-labeled anti-CEA monoclonal antibodies for immunoscintigraphy in colorectal cancer.
Behr TM; Becker WS; Bair HJ; Klein MW; Stühler CM; Cidlinsky KP; Wittekind CW; Scheele JR; Wolf FG
J Nucl Med; 1995 Mar; 36(3):430-41. PubMed ID: 7884505
[TBL] [Abstract][Full Text] [Related]
35. [Diagnostic imaging of lobular carcinoma of the breast: mammographic, ultrasonographic and MR findings].
Bazzocchi M; Facecchia I; Zuiani C; Puglisi F; Di Loreto C; Smania S
Radiol Med; 2000 Dec; 100(6):436-43. PubMed ID: 11307504
[TBL] [Abstract][Full Text] [Related]
36. [Tumor diagnosis by immunoscintigraphy with anti-CEA antibodies (Tc-99m MAK BW 431/26)].
Kroiss A; Tuchmann A; Schüller J; Weiss W; Wirth M; Auinger C; Neumayr A
Wien Klin Wochenschr; 1989 Sep; 101(18):621-6. PubMed ID: 2815778
[TBL] [Abstract][Full Text] [Related]
37. Pathologic findings from the Breast Cancer Surveillance Consortium: population-based outcomes in women undergoing biopsy after screening mammography.
Weaver DL; Rosenberg RD; Barlow WE; Ichikawa L; Carney PA; Kerlikowske K; Buist DS; Geller BM; Key CR; Maygarden SJ; Ballard-Barbash R
Cancer; 2006 Feb; 106(4):732-42. PubMed ID: 16411214
[TBL] [Abstract][Full Text] [Related]
38. Invasive lobular carcinoma of the breast: mammographic and sonographic evaluation.
Albayrak ZK; Onay HK; Karatağ GY; Karatağ O
Diagn Interv Radiol; 2011 Sep; 17(3):232-8. PubMed ID: 20706979
[TBL] [Abstract][Full Text] [Related]
39. The value of mammography within 1 year of conservative surgery for breast cancer.
Lewis JL; Tartter PI
Ann Surg Oncol; 2012 Oct; 19(10):3218-22. PubMed ID: 22766990
[TBL] [Abstract][Full Text] [Related]
40. Age-related differences in patients with nonpalpable breast carcinomas.
Wazer DE; Gage I; Homer MJ; Krosnick SH; Schmid C
Cancer; 1996 Oct; 78(7):1432-7. PubMed ID: 8839548
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
